bayer ag-reg (BAYZF) Key Developments
Bayer AG Announces Reorganization; Announces Executive Changes, Effective January 1, 2016
Sep 18 15
The Supervisory Board of Bayer AG approved the reorganization proposed by the Board of Management. From January 1, 2016, the company's business will be managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. The present structure of a strategic management holding company and operational subgroups will be replaced by an integrated organization under the umbrella of the strong Bayer brand. The aim of the new organization is to provide the best possible support to Bayer's strategy as a leading Life Science company and to put Bayer in an even stronger position.
In the new organization, the Board of Management of Bayer AG will also hold overall responsibility for business operations. For this reason, the Supervisory Board resolved to appoint the heads of the divisions – Dieter Weinand (Pharmaceuticals), Erica Mann (Consumer Health) and Liam Condon (Crop Science) - to the Board of Management effective January 1, 2016. On the same date, Dr. Hartmut Klusik will also join the Board of Management of Bayer AG as the new Labor Director and Board member responsible for Human Resources, Technology and Sustainability. He will succeed Michael König, who has requested that his contract not be extended. Klusik is currently responsible for Product Supply on the Board of Management of Bayer HealthCare AG.
Bayer AG Presents at Bank of America Merill Lynch Global Healthcare Conference, Sep-17-2015
Sep 17 15
Bayer AG Presents at Bank of America Merill Lynch Global Healthcare Conference, Sep-17-2015 . Venue: London, United Kingdom.
Bayer AG Presents at BioPharm America 2015, Sep-15-2015 09:00 AM
Sep 12 15
Bayer AG Presents at BioPharm America 2015, Sep-15-2015 09:00 AM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.
Bayer Group Opens its First Medical Devices Plant in Costa Rica
Aug 27 15
Bayer Group opened a plant for the production of a non-reversible permanent contraceptive device, with an investment of USD 12 million and an initial employment generation for up to 75 people. The plant located in the Zona Franca Metropolitana in Barreal de Heredia covers about 1,400 square meters, dedicated to the assembly of this medical device and has the ISO 13485 certification, which will allow Bayer to market this product in Europe and Canada. It also has the approval of the US Food and Drug Administration (FDA) to sell it in the United States.
Bayer AG Presents at Berenberg German Corporate Conference 2015, Sep-22-2015
Aug 6 15
Bayer AG Presents at Berenberg German Corporate Conference 2015, Sep-22-2015 . Venue: Dolce Munich Unterschleissheim, Andreas-Danzer-Weg 1, 85716 Unterschleissheim, Germany. Speakers: Carri Duncan von Stackelber, IR Manager, Juergen Beunink, IR Manager.